🔗 Share this article

An underground economy for unlicensed weight-loss medications is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Treatment Gaining Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to message these profiles privately for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a flourishing market exists on Telegram, where groups with thousands of members share comparison photos, injection guides and claims of rapid UK delivery. Vendors market the drug there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Voice Worries

However, doctors and chemists have cautions that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.

Some professionals said the popularity for the experimental drug could be linked to the rising price of approved weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach pharmaceutical, advertising, and customer laws, risking penalties, legal action or prison.

Platform Response and Material Elimination

Based on TikTok, the platform has removed problematic content and prohibited associated keywords and search suggestions. The company said it was dedicated to maintaining the service secure and investing in enhancing compliance measures.

Online Trading Operations

Research also discovered groups with up to nine thousand participants marketing retatrutide using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with thousands of users, populated with photos of weight loss, glowing testimonials and detailed guides for mixing or injecting at home.

Within minutes of joining one community, a seller shared WhatsApp details, where most transactions occur. The vendor provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.

Item Details and Pricing

Within these groups, messages show black plastic parcels with postal service stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20 milligrams. When questioned how long a pen should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service stated it actively monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they can’t verify. Even if the science behind retatrutide is sound, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her team has previously encountered patients injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject patients to possibly serious medical dangers”.